Dr. Willy Hugo
University of California, Los Angeles, USA
Dr. Willy Hugo earned his PhD in Computational Biology from the National University of Singapore in 2011. He had published multiple high impact papers on the mechanisms of resistance to targeted- and immunotherapy in melanoma during his postdoctoral training at UCLA. Currently, Dr. Hugo is an Assistant Adjunct Professor at the Department of Medicine, UCLA. His lab is studying the role of the interaction between tumor cells and the immune/stromal cells in the tumor microenvironment and how such interaction influences the development of resistance toward targeted- and immunotherapies in cancer. By utilizing a combination of the traditional bulk sequencing of tumors, the more contemporary single cell omics analysis and co-culture modeling approach of cancer immune cell interaction, he aims to uncover novel, targetable mechanism of resistance in melanoma.
More speakers will be updated.